- 1-10 Employees
- Based in Research Triangle Park, North Carolina
Fennec Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting.
REPORT RATINGS4.8 / 5.0 (160)
Fennec Pharmaceuticals reports have an aggregate usefulness score of 4.8 based on 160 reviews.
Most Recent Annual Report
2022 Annual Report and Form 10K
Older/Archived Annual Reports